Gujarat Themis Biosyn Ltd. (GUJTHEM) Share Price Rise Streak Continues in Second Straight Session
- September 8, 2026
- Posted by: Harsh Piplani
- Category: News
Gujarat Themis Biosyn Ltd. Share Price Rise Streak is now in its second straight session, with the cumulative move standing at 10.87% from Rs 411.75. The latest Univest data confirms the pattern through price action alone, without assigning a company-specific trigger.
Gujarat Themis Biosyn Ltd. Share Price was at Rs 456.5, compared with the previous close of Rs 429.65. The stock opened at Rs 429.35, touched a high of Rs 456.5 and a low of Rs 429.35, while turnover stood at Rs 1.92 Cr and market capitalisation was Rs 5,591.97 Cr.
Gujarat Themis Biosyn Ltd. Share Price Rise Streak: Consecutive Gain Analysis
Gujarat Themis Biosyn Ltd. (GUJTHEM) rose to Rs 456.5 from the previous close of Rs 429.65, a move of Rs 26.85 or 6.25%. The stock opened at Rs 429.35, reached a high of Rs 456.5, recorded a low of Rs 429.35.
Gujarat Themis Biosyn Ltd. Share Price Rise Streak is best read through the two-session move, not just the latest print. The stock traded at Rs 456.5 after rising Rs 26.85, or 6.25%, from the previous close, and the latest Univest figures show the move held through the full session range.
The day began near the prior close at Rs 429.35 and never slipped below that level, which kept the session constructive from the start. By touching Rs 456.5, the stock matched its session high and gave the streak a cleaner finish. For readers following Gujarat Themis Biosyn Ltd. Share Price Rise Streak, the key takeaway is continuity: the market has now accepted higher pricing on back-to-back days.
The cumulative advance of 10.87% from Rs 411.75 gives the streak more meaning than a one-day gain. It shows that the first higher close was followed by another, which is what places Gujarat Themis Biosyn Ltd. Share Price Rise Streak in a stronger short-term context. Turnover of Rs 1.92 Cr also indicates active participation alongside the price move.
Gujarat Themis Biosyn Ltd. (GUJTHEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 5,591.97 crore |
| P/E Ratio | 114.86x |
| P/B Ratio | 5.33x |
| ROE | 21.69% |
| ROCE | 27.48% |
| EPS | Rs 3.74 |
| Book Value Per Share | Rs 80.59 |
| Dividend Yield | 0.16% |
Gujarat Themis Biosyn Ltd. (GUJTHEM) fundamental metrics show P/E 114.86x, P/B 5.33x, ROE 21.69%, ROCE 27.48%. These figures provide context only and are not a buy or sell signal.
Gujarat Themis Biosyn Ltd. has a market capitalisation of Rs 5591.97 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 114.86x, P/B at 5.33x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 21.69% and ROCE of 27.48%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.74, book value per share of Rs 80.59, dividend yield of 0.16%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.52x, median ROE of 11.82%, median ROCE of 13.71%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 114.86x |
| Benchmark Median P/E | 32.52x |
| Benchmark Average P/E | 49x |
| Benchmark P/E Range | 3.35x to 654.07x |
| Company P/B Ratio | 5.33x |
| Benchmark Median P/B | 3x |
| Company ROE | 21.69% |
| Benchmark Median ROE | 11.82% |
| Company ROCE | 27.48% |
| Benchmark Median ROCE | 13.71% |
| Company Market Capitalisation | Rs 5,591.97 crore |
| Benchmark Median Market Cap | Rs 701.65 crore |
Gujarat Themis Biosyn Ltd. (GUJTHEM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Gujarat Themis Biosyn Ltd. (GUJTHEM) has a P/E ratio of 114.86x, which is above the benchmark median of 32.52x, a difference of +253.2%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Gujarat Themis Biosyn Ltd. (GUJTHEM) has a ROE of 21.69%, which is above the benchmark median of 11.82%, a difference of +83.5%. Gujarat Themis Biosyn Ltd. (GUJTHEM) has a ROCE of 27.48%, which is above the benchmark median of 13.71%, a difference of +100.44%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,55,633.71 | 37.69 | 5.27 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,41,576.41 | 84.45 | 13.99 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,84,478.41 | 85.68 | 20.82 | 26.76 | 19.27 |
| Cipla Ltd. | CIPLA | 1,11,888.39 | 33.46 | 3.21 | 11.83 | 16 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,11,820.18 | 25.53 | 4.27 | 19.69 | 21.39 |
Gujarat Themis Biosyn Ltd. (GUJTHEM) has a P/E ratio of 114.86x compared with the displayed peer median of 37.69x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 21.69% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 27.48% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Gujarat Themis Biosyn Ltd. (GUJTHEM) has a market capitalisation of Rs 5,591.97 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Gujarat Themis Biosyn Ltd.
- Gujarat Themis Biosyn Ltd. Share Price Rise Streak has reached a second straight session.
- The cumulative streak gain is 10.87% from Rs 411.75.
- The stock was at Rs 456.5, near the session high for the day.
- ROE of 21.69% and ROCE of 27.48% remain above industry medians.
- Sector valuation sits above the industry benchmark on both P/E and P/B.
About Gujarat Themis Biosyn Ltd.
Gujarat Themis Biosyn Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is listed under the symbol GUJTHEM, and the latest Univest data places it among mid-cap pharma names that investors often assess through valuation and profitability together. That makes the Gujarat Themis Biosyn Ltd. Share Price Rise Streak easier to read in context.
The company snapshot includes market capitalisation of Rs 5,591.97 Cr, P/E of 114.86, P/B of 5.33, ROE of 21.69%, ROCE of 27.48%, EPS of Rs 3.74, book value of Rs 80.59 and dividend yield of 0.16%. Those numbers frame the business profile behind the latest price move.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Gujarat Themis Biosyn Ltd. Share Price rising today?
Ans. The latest Univest figures show a second straight higher close and a 10.87% cumulative move from Rs 411.75. They confirm the streak but do not identify a company-specific trigger behind the rise.
What is Gujarat Themis Biosyn Ltd. Share Price today?
Ans. Gujarat Themis Biosyn Ltd. Share Price was Rs 456.5, up Rs 26.85 or 6.25% from the previous close of Rs 429.65. The stock also touched Rs 456.5 as the day high.
What does the second straight session mean for Gujarat Themis Biosyn Ltd. Share Price Rise Streak?
Ans. It means the stock has recorded consecutive higher closes. That matters because it suggests the latest move was followed through rather than reversing after one session, with the cumulative gain reaching 10.87%.
How strong is the valuation in Gujarat Themis Biosyn Ltd. analysis?
Ans. The latest Univest data shows a P/E of 114.86 and a P/B of 5.33. Both stand above the industry medians, so the stock appears premium-priced relative to the same industry benchmark.
What do ROE and ROCE say about Gujarat Themis Biosyn Ltd. Share Price?
Ans. ROE of 21.69% and ROCE of 27.48% indicate stronger return ratios than the industry medians. That gives the stock a profitability backdrop that is noticeably better than the benchmark group.
How does Gujarat Themis Biosyn Ltd. compare with pharma peers?
Ans. Gujarat Themis Biosyn Ltd. has a much smaller market capitalisation than the large pharma names shown in the peer table. Even so, its ROCE remains strong within the comparison set, which keeps it visible.
What is the market capitalisation in Gujarat Themis Biosyn Ltd. Share Price today?
Ans. Market capitalisation was Rs 5,591.97 Cr according to latest Univest data. That places Gujarat Themis Biosyn Ltd. in a mid-cap bracket and helps explain its position within the Healthcare sector.
Why does the streak matter more than one session for Gujarat Themis Biosyn Ltd. Share Price Rise Streak?
Ans. Two higher closes in a row show persistence, and the 10.87% cumulative move from Rs 411.75 gives the pattern more weight. It is the follow-through that makes the stock more noticeable today.
Track Gujarat Themis Biosyn Ltd. (GUJTHEM) Share Price on Univest
Use Gujarat Themis Biosyn Ltd. (GUJTHEM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
